Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion type Assertion NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_head.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion description "[It was also revealed that FOXA1 siRNA treatment of esophageal cancer cells reduced the mRNA level of both KRT7 and a stabilizer of epithelial-mesenchymal transition (EMT) regulator LOXL2, and that both FOXA1 and LOXL2 siRNAs reduced invasion and migration of ESCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_provenance.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion evidence source_evidence_literature NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_provenance.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion SIO_000772 20043065 NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_provenance.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion wasDerivedFrom befree-2016 NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_provenance.
- NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_assertion wasGeneratedBy ECO_0000203 NP784391.RAIr72ykyhO6v5Rj3Lrv7B55lnedXY1yAGIrcaHAPO-yU130_provenance.